Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLDOPA vs METHYLENE BLUE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

METHYLDOPA vs METHYLENE BLUE: Safety Overview

Metric METHYLDOPA METHYLENE BLUE
Total FAERS Reports 2,604 846
Deaths Reported 73 165
Death Rate 2.8% 19.5%
Hospitalizations 728 536
Average Patient Age 32.1 yrs 48.0 yrs
% Female Patients 77.1% 49.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 8, 2016
Manufacturer Rising Pharma Holdings, Inc. Zydus Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription